Rafael Holdings, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 520 BROAD STREET, NEWARK, NJ, 07120
Mailing Address 520 BROAD STREET, NEWARK, NJ, 07120
Phone 212-658-1450
Fiscal Year End 0731
EIN 822296593
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
| 4 Insider stock transaction report | December 16, 2025 | View on SEC |
| 10-Q Quarterly financial report | December 12, 2025 | View on SEC |
Annual Reports
10-K October 29, 2025
- Lead drug Trappsol® Cyclo™ in Phase 3 trials targeting Niemann-Pick Disease
- Partnered to share drug development costs amid shrinking cash reserves
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.